Charles River Laboratories Net Income 2010-2024 | CRL

Charles River Laboratories annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Charles River Laboratories net income for the quarter ending December 31, 2024 was $-0.225B, a 220.49% decline year-over-year.
  • Charles River Laboratories net income for the twelve months ending December 31, 2024 was $0.010B, a 97.83% decline year-over-year.
  • Charles River Laboratories annual net income for 2024 was $0.01B, a 97.83% decline from 2023.
  • Charles River Laboratories annual net income for 2023 was $0.475B, a 2.39% decline from 2022.
  • Charles River Laboratories annual net income for 2022 was $0.486B, a 24.36% increase from 2021.
Charles River Laboratories Annual Net Income
(Millions of US $)
2024 $10
2023 $475
2022 $486
2021 $391
2020 $364
2019 $252
2018 $226
2017 $123
2016 $155
2015 $149
2014 $127
2013 $103
2012 $97
2011 $110
2010 $-337
2009 $114
Charles River Laboratories Quarterly Net Income
(Millions of US $)
2024-12-31 $-225
2024-09-30 $69
2024-06-30 $94
2024-03-31 $73
2023-12-31 $187
2023-09-30 $87
2023-06-30 $97
2023-03-31 $103
2022-12-31 $187
2022-09-30 $96
2022-06-30 $109
2022-03-31 $93
2021-12-31 $138
2021-09-30 $103
2021-06-30 $88
2021-03-31 $62
2020-12-31 $143
2020-09-30 $103
2020-06-30 $67
2020-03-31 $51
2019-12-31 $80
2019-09-30 $73
2019-06-30 $44
2019-03-31 $55
2018-12-31 $60
2018-09-30 $60
2018-06-30 $54
2018-03-31 $53
2017-12-31 $-30
2017-09-30 $52
2017-06-30 $54
2017-03-31 $47
2016-12-31 $45
2016-09-30 $38
2016-06-30 $35
2016-03-31 $37
2015-12-31 $32
2015-09-30 $37
2015-06-30 $49
2015-03-31 $32
2014-12-31 $27
2014-09-30 $32
2014-06-30 $35
2014-03-31 $32
2013-12-31 $19
2013-09-30 $31
2013-06-30 $27
2013-03-31 $26
2012-12-31 $18
2012-09-30 $22
2012-06-30 $30
2012-03-31 $26
2011-12-31 $27
2011-09-30 $19
2011-06-30 $32
2011-03-31 $31
2010-12-31 $-344
2010-09-30 $-25
2010-06-30 $14
2010-03-31 $17
2009-12-31 $18
2009-09-30 $37
2009-06-30 $34
2009-03-31 $25
Sector Industry Market Cap Revenue
Medical Medical Services $6.822B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $136.657B 25.63
Elevance Health (ELV) United States $88.114B 11.37
CVS Health (CVS) United States $76.496B 9.51
Cencora (COR) United States $55.428B 19.28
DiDi Global (DIDIY) China $22.215B 33.71
Natera (NTRA) United States $20.400B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.620B 13.36
EUROFINS SCIENT (ERFSF) Luxembourg $12.158B 0.00
CochLear (CHEOY) Australia $11.298B 0.00
Doximity (DOCS) United States $10.912B 50.83
Revvity (RVTY) United States $10.655B 18.34
ICON (ICLR) Ireland $10.552B 9.81
Viatris (VTRS) United States $10.317B 3.54
Avantor (AVTR) United States $8.750B 12.71
Medpace Holdings (MEDP) United States $8.519B 22.63
HealthEquity (HQY) United States $8.446B 41.55
Sonic Healthcare (SKHHY) Australia $8.201B 0.00
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.185B 38.74
Bausch + Lomb (BLCO) Canada $4.171B 24.58
Sotera Health (SHC) United States $3.616B 20.55
Surgery Partners (SGRY) United States $3.029B 39.39
Alignment Healthcare (ALHC) United States $2.948B 0.00
Concentras Parent (CON) United States $2.925B 16.90
Organon (OGN) United States $2.280B 2.42
Ardent Health Partners (ARDT) United States $2.179B 9.29
Progyny (PGNY) United States $1.882B 41.42
Premier (PINC) United States $1.877B 14.24
GeneDx Holdings (WGS) United States $1.815B 69.90
PACS (PACS) United States $1.625B 0.00
GoodRx Holdings (GDRX) United States $1.432B 28.64
Pediatrix Medical (MD) United States $1.278B 9.73
Teladoc Health (TDOC) United States $1.272B 0.00
Establishment Labs Holdings (ESTA) $1.059B 0.00
Agilon Health (AGL) United States $1.056B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
Nutex Health (NUTX) United States $0.967B 14.61
CareDx (CDNA) United States $0.896B 14.00
AMN Healthcare Services Inc (AMN) United States $0.857B 8.02
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.681B 4.59
InnovAge Holding (INNV) United States $0.570B 0.00
Enhabit (EHAB) United States $0.545B 44.83
Auna S.A (AUNA) Luxembourg $0.514B 13.63
Sonida Senior Living (SNDA) United States $0.493B 0.00
LifeMD (LFMD) United States $0.439B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.367B 0.00
SBC Medicals (SBC) United States $0.361B 0.00
Oncology Institute (TOI) United States $0.230B 0.00
Beauty Health (SKIN) United States $0.217B 0.00
Performant Healthcare (PHLT) United States $0.204B 0.00
DocGo (DCGO) United States $0.143B 23.33
Sera Prognostics (SERA) United States $0.090B 0.00
KindlyMD (KDLY) United States $0.083B 0.00
So-Young (SY) China $0.083B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.071B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Basel Medical Group (BMGL) Singapore $0.049B 0.00
Pheton Holdings (PTHL) China $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Biodesix (BDSX) United States $0.032B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00